87037-69-2

Usage

Uses

Used in Pharmaceutical Industry:
(2R)-2-(Benzyloxy)-1-propanol is used as an intermediate in the production of pharmaceuticals for its ability to facilitate the synthesis of various organic compounds.
Used in Agrochemical Industry:
(2R)-2-(Benzyloxy)-1-propanol is used as an intermediate in the production of agrochemicals, contributing to the development of various organic compounds for agricultural applications.
Used in Organic Synthesis:
(2R)-2-(Benzyloxy)-1-propanol is used as a solvent in certain reactions and in organic synthesis, enabling the creation of a range of chemical products.
Used in Chemical Reactions:
(2R)-2-(Benzyloxy)-1-propanol is used as a solvent in specific chemical reactions, aiding in the process and potentially improving the efficiency and yield of the reaction.

Upstream product

• 33106-32-0 2-(benzyloxy)propanoic acid 
• 57-55-6 propylene glycol 
• 100-44-7 benzyl chloride 
• 547-64-8 methyl lactate 
• 100-39-0 benzyl bromide 
• 100-52-7 benzaldehyde 
• 100-51-6 benzyl alcohol 
• 67-56-1 methanol 
• 622-08-2 2-Benzyloxyethanol 
• 53346-05-7 (R)-2-benzyloxypropanal 
• 33106-26-2 2-benzyloxypropanol 
• 2040-44-0 ethyl 2-benzyloxypropionate 
• 1105507-44-5 1-(((R)-1-(4-methoxybenzyloxy)propan-2-yloxy)methyl)benzene 
• 1220352-28-2 (2S,4R)-3-[(R)-2-benzyloxypropanoyl]-2-trifluoromethyl-4-phenyl-1,3-oxazolidine 

Downstream Products

• 111752-64-8 ethyl (Z)-4-benzyloxypent-2-enoate 
• 17229-24-2 2-benzyloxy-1-chloropropane 
• 33106-29-5 2-benzyloxypropyl iodide 
• 53346-05-7 2-(benzyloxy)propanal 
• 33106-64-8 (S)-2-(benzyloxy)propan-1-ol 
• 135364-14-6 (R,S)-Diethyl-(2-benzyloxypropyl)phosphonat 
• 22539-93-1 3-benzyloxypropanone 
• 53346-05-7 (R)-2-benzyloxypropanal 
• 89387-39-3 2-O-benzyl-1-O-<4-O-<4-O-(β-D-glucopyranosyl)-β-D-glucopyranosyl>-2,3,6-tri-O-benzyl-α-D-glucopyranosyl>-3-deoxy-2(R)-glycerol 
• 160278-26-2 3-[2(R)-Benzyloxypropyl]amino-3-methyl-N-[ 2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepin-3(R)-yl]-butanamide, trifluoroacetate 
• 4254-14-2 (2R)-propane-1,2-diol 

Relevant academic research and scientific papers

MACROCYCLES AND THEIR USE

The present disclosure relates to macrocyclic compounds, pharmaceutical compositions containing macrocyclic compounds, and methods of using macrocyclic compounds to treat disease, such as cancer.

6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS

The present disclosure provides 6-heteroaryloxy benzimidazole and azabenzimidazole compounds and compositions thereof useful for inhibiting JAK2.

Benzoxaborole Catalyst for Site-Selective Modification of Polyols

The site-selective modification of polyols bearing several hydroxyl groups without the use of protecting groups remains a significant challenge in synthetic chemistry. To address this problem, novel benzoxaborole derivatives were designed as efficient catalysts for the highly site-selective and protecting-group-free modification of polyols. To identify the effective substituent groups enhancing the catalytic activity and selectivity, a series of benzoxaborole catalysts 1a–k were synthesized. In-depth analysis for the substituent effect revealed that 1i–k, bearing multiple electron-withdrawing fluoro- and trifluoromethyl groups, exhibited the greatest catalytic activity and selectivity. Moreover, 1i-catalyzed benzoylation, tosylation, benzylation, and glycosylation of various cis-1,2-diol derivatives proceeded with good yield and site-selective manner.

Regio/site-selective alkylation of substrates containing a: Cis -, 1,2- or 1,3-diol with ferric chloride and dipivaloylmethane as the catalytic system

In this study, we reported the regio/site-selective alkylation of substrates containing a cis-, 1,2- or 1,3-diol with FeCl3 as a key catalyst. A catalytic system consisting of FeCl3 (0.01-0.1 equiv.) and dipivaloylmethane (FeCl3/dipivaloylmethane = 1/2) was used to catalyze the alkylation in the presence of a base. The produced selectivities and isolated yields were similar to those obtained by methods using the same amount of FeL3 (L = acylacetone ligand) as the catalyst in most cases. The previously reported FeL3 catalysts for alkylation are not commercially available and have to be synthesized prior to use. In contrast, FeCl3 and dipivaloylmethane (Hdipm) are very common and inexpensive nontoxic reagents in the lab, thereby making the method much greener and easier to handle. Mechanism studies confirmed for the first time that FeCl3 initially reacts with two equivalents of Hdipm to form [Fe(dipm)3] in the presence of a base in acetonitrile, followed by the formation of a five or six-membered ring intermediate between [Fe(dipm)3] and two hydroxyl groups of the substrate. A subsequent reaction between the cyclic intermediate and the alkylating agent results in selective alkylation of the substrate.

C -Methylation of Alcohols, Ketones, and Indoles with Methanol Using Heterogeneous Platinum Catalysts

A versatile, selective, and recyclable heterogeneous catalytic method for the methylation of C-H bonds in alcohols, ketones, and indoles with methanol under oxidant-free conditions using a Pt-loaded carbon (Pt/C) catalyst in the presence of NaOH is reported. This catalytic system is effective for various methylation reactions: (1) the β-methylation of primary alcohols, including aryl, aliphatic, and heterocyclic alcohols, (2) the α-methylation of ketones, and (3) the selective C3-methylation of indoles. The reactions are driven by a borrowing-hydrogen mechanism. The reaction begins with the dehydrogenation of the alcohol(s) to afford aldehydes, which subsequently undergo a condensation reaction with the nucleophile (aldehyde, ketone, or indole), followed by hydrogenation of the condensation product by Pt-H species to yield the desired product. In all of the methylation reactions explored in this study, the Pt/C catalyst exhibits a significantly higher turnover number than other previously reported homogeneous catalytic systems. Moreover, it is demonstrated that the high catalytic activity of Pt can be rationalized in terms of the adsorption energy of hydrogen on the metal surface, as revealed by density functional theory calculations on different metal surfaces.

IMIDAZOPYRIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Disclosed are compounds of Formula (I), including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS.

Epoxide hydrolysis and alcoholysis reactions over crystalline Mo-V-O oxide

Crystalline Mo-V-O oxides have been used as a catalyst for the hydrolysis and alcoholysis of propylene oxide to diols and ethers, respectively. Relationships between the active crystal facet, the acidity of Mo-V-O catalysts and the activity have been established. Our results indicate that the a-b plane is the active facet for the hydrolysis reaction.

Stereoselective synthesis of C19-C27 fragment of bryostatin 11

A convergent synthesis of C19-C27 fragment (2) of bryostatin-11 is described. The key steps involved in this approach are kinetic resolution, Grignard reaction, and Sharpless dihydroxylation. AIBN catalyzed radical cyclization strategy has been used for the first time to construct the six-membered pyran system.

Stereoselective synthesis of C19-C27 fragment of bryostatin 11

A convergent synthesis of C19-C27 fragment (2) of bryostatin-11 is described. The key steps involved in this approach are kinetic resolution, Grignard reaction, and Sharpless dihydroxylation. AIBN catalyzed radical cyclization strategy has been used for the first time to construct the six-membered pyran system.

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

Disclosed herein are compounds that inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases using the compounds.